Search Results - Jason D. Lickliter

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    First‐in‐human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN‐101, a dual CD28/ICOS antagonist, in healthy adult subjects by Jing Yang, Jason D. Lickliter, Jan L. Hillson, Gary D. Means, Russell J. Sanderson, Kay Carley, Almudena Tercero, Kristi L. Manjarrez, Jennifer R. Wiley, Stanford L. Peng

    Published in Clinical and Translational Science (2021-07-01)
    Get full text
    Article


  2. 2

    A phase 1 clinical trial of the sigma‐2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease by Michael Grundman, Roger Morgan, Jason D. Lickliter, Lon S. Schneider, Steven DeKosky, Nicholas J. Izzo, Robert Guttendorf, Michelle Higgin, Julie Pribyl, Kelsie Mozzoni, Hank Safferstein, Susan M. Catalano

    Get full text
    Article


  3. 3

    Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial. by Angus H Forster, Katey Witham, Alexandra C I Depelsenaire, Margaret Veitch, James W Wells, Adam Wheatley, Melinda Pryor, Jason D Lickliter, Barbara Francis, Steve Rockman, Jesse Bodle, Peter Treasure, Julian Hickling, Germain J P Fernando

    Published in PLoS Medicine (2020-03-01)
    Get full text
    Article


  4. 4

    A randomized, double-blind, Phase 1, single- and multiple-dose placebo-controlled study of the safety and pharmacokinetics of IN-006, an inhaled antibody treatment for COVID-19 in... by Thomas R. Moench, Lakshmi Botta, Brian Farrer, Jason D. Lickliter, Hyunah Kang, Yoona Park, Cheolmin Kim, Marshall Hoke, Miles Brennan, Morgan D. McSweeney, Zachary Richardson, John B. Whelan, Jong Moon Cho, Soo Young Lee, Frances Faurot, Jeff Hutchins, Samuel K. Lai

    Published in EBioMedicine (2025-03-01)
    Get full text
    Article


  5. 5

    A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study by Joshua Osowicki, MBBS, Kristy I Azzopardi, BSc, Loraine Fabri, MD, Hannah R Frost, PhD, Tania Rivera-Hernandez, PhD, Melanie R Neeland, PhD, Alana L Whitcombe, BSc, Anneke Grobler, PhD, Sarah J Gutman, MBBS, Ciara Baker, MSc, Janet M F Wong, MBBS, Jason D Lickliter, PhD, Claire S Waddington, PhD, Manisha Pandey, PhD, Tibor Schuster, PhD, Allen C Cheng, ProfPhD, Andrew J Pollard, ProfPhD, James S McCarthy, ProfMD, Michael F Good, ProfPhD, James B Dale, ProfMD, Michael Batzloff, PhD, Nicole J Moreland, PhD, Mark J Walker, ProfPhD, Jonathan R Carapetis, ProfPhD, Pierre R Smeesters, ProfPhD, Andrew C Steer, ProfPhD

    Published in The Lancet Microbe (2021-07-01)
    Get full text
    Article


Search Tools: